Results 311 to 320 of about 4,459,968 (325)
Some of the next articles are maybe not open access.

Long-term safety of ketamine and esketamine in treatment of depression

Expert Opinion on Drug Safety, 2022
Introduction Ketamine can produce rapid-acting antidepressant effects. Esketamine (Spravato), the S-enantiomer of racemic ketamine, was approved by the FDA for treatment-resistant depression in 2019.
Sina Nikayin   +3 more
semanticscholar   +1 more source

Long-term depression in the CNS

Nature Reviews Neuroscience, 2010
G. Collingridge   +3 more
semanticscholar   +1 more source

Activation of p75NTR by proBDNF facilitates hippocampal long-term depression

Nature Neuroscience, 2005
N. Woo   +7 more
semanticscholar   +1 more source

Long-term depression as a model of cerebellar plasticity.

Progress in Brain Research, 2014
Masao Ito   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy